Aquestive Therapeutics, Inc.
AQST· Nasdaq
AQSTAquestive Therapeutics, Inc.
Source filing unavailable
| Metric | Q1 2018 | Q1 2017 |
|---|---|---|
| Revenue | $23.41M | $16.44M |
| Net Income | $4.10M | -$1.46M |
| EPS Diluted | $0.27 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aquestive Therapeutics, Inc. · CIK 1398733 · Engraved from SEC EDGAR
